Pharma FDI cap retained at 100%; CCI to be watchdog

Foreign Direct Investment (FDI) in the pharmaceutical sector would not be under the automatic route anymore, but will need prior Foreign Investment Promotion Board (FIPB) approval, reports CNBC-TV18's Rituparno Bhuyan.

October 11, 2011 / 09:06 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Foreign Direct Investment (FDI) in the pharmaceutical sector would not be under the automatic route anymore, but will need prior Foreign Investment Promotion Board (FIPB) approval, reports CNBC-TV18

first published: Oct 10, 2011 09:02 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!